Artículos por temáticas

The Usefulness of Wearable Sensors for Detecting Freezing of Gait in Parkinson's Disease: A Systematic Review

Gregorčič M, Georgiev D.

Sensors (Basel). 2025 Aug 16;25(16):5101. doi: 10.3390/s25165101.

Challenging the impostor: a scoping review of the pharmacological management of Capgras syndrome in Parkinson's disease and Lewy bodies dementia

Luca A, Luca M, Ferri R, Serretti A.

Neurol Sci. 2025 Jul;46(7):2979-2984. doi: 10.1007/s10072-025-08078-x. Epub 2025 Mar 6.

Research progress of assessment tools for Parkinson's disease psychosis in China

Wang S, Yang B, Lu P, Chen Y, Dai J, Zhao L, Wang M, Yu J, Zhang L.

Front Psychiatry. 2025 Jul 10;16:1588618. doi: 10.3389/fpsyt.2025.1588618. eCollection 2025.

Parkinson Disease Signaling Pathways, Molecular Mechanisms, and Potential Therapeutic Strategies: A Comprehensive Review

Khan MS, Nasiripour S, Bopassa JC.

Int J Mol Sci. 2025 Jul 3;26(13):6416. doi: 10.3390/ijms26136416.

Aerobic exercise-induced changes in fluid biomarkers in Parkinson's disease

Luthra NS, Mehta N, Munoz MJ, Fantuzzi G, Lamotte G, Haus JM, McFarland NR, Tansey MG, Gonzalez-Latapi P, Caraveo G, Kang UJ, Corcos DM.

NPJ Parkinsons Dis. 2025 Jul 1;11(1):190. doi: 10.1038/s41531-025-01042-8.

The role of gasotransmitters in Parkinson's disease: Interplay of nitric oxide, carbon monoxide, and hydrogen sulfide

O'Connor JL, Fountos DM, Firouzan B, Azizi F, Ghasemi R, Kashfi K.

Neurotherapeutics. 2025 Jul 25:e00710. doi: 10.1016/j.neurot.2025.e00710. Online ahead of print.

Efficacy and safety of Wuling capsule for the treatment of mild depression in patients with early Parkinson's disease in China: a randomized clinical trial

Zhao Y, Li L, Huang D, Li W, Zhao Q, Liu H, Xiong R, Liu M, Gan J, Wu N, Liu Z, Chen X, Zhang S, Feng H, Lu J, Chen X, Zhang Y, Zhao X, Liu Z.

BMC Complement Med Ther. 2025 Jul 9;25(1):246. doi: 10.1186/s12906-025-04991-y.

The effect of melatonin on sleep quality and daytime sleepiness in Parkinson's disease: A systematic review and meta-analysis of randomized placebo-controlled trials

Zrineh A, Akwan R, Elsharkawy MM, Douden B, Sleibi W, Eldesouki M.

Sleep Med. 2025 Jul;131:106540. doi: 10.1016/j.sleep.2025.106540. Epub 2025 Apr 23.

Mathematical Modeling of Neuroinflammation in Neurodegenerative Diseases

Foster-Powell A, Rostami-Hodjegan A, Meno-Tetang G, Mager DE, Ogungbenro K.

CPT Pharmacometrics Syst Pharmacol. 2025 Aug 13. doi: 10.1002/psp4.70064. Online ahead of print.

The Global Landscape of Genetic Variation in Parkinson's disease: Multi-Ancestry Insights into Established Disease Genes and their Translational Relevance

Lange LM, Fang ZH, Makarious MB, Kuznetsov N, Brolin KA, Ballard S, Bardien S, Doquenia ML, Heutink P, Houlden H, Iwaki H, Jasaityte S, Jones L, Junker J, Kaiyrzhanov R, Koretsky MJ, Kumar KR; Latin A

medRxiv [Preprint]. 2025 Jul 11:2025.07.08.25330815. doi: 10.1101/2025.07.08.25330815.

Healthcare Complexities in Neurodegenerative Proteinopathies: A Narrative Review

Fereshtehnejad SM, Lökk J.

Healthcare (Basel). 2025 Jul 31;13(15):1873. doi: 10.3390/healthcare13151873.

Approach to Cardiovascular Autonomic Dysfunction in Patients with Synucleinopathies

Lenka A, Beach P.

Mov Disord Clin Pract. 2025 Aug 7. doi: 10.1002/mdc3.70268. Online ahead of print.

The Role of the human microbiome in neurodegenerative diseases: A Perspective

Mukherjea N, Khandelwal A, Saluja R, Kalra N.

Curr Genet. 2025 Aug 21;71(1):17. doi: 10.1007/s00294-025-01319-8.

Neuroprotective effects of essential oils in animal models of Alzheimer's and Parkinson's disease: a systematic review

Macedo ADES, Ferreira TM, Krejcová LV, Rocha FAF, da Silva JKR, Pedrosa LRR, Gomes BD.

PeerJ. 2025 Jul 10;13:e19643. doi: 10.7717/peerj.19643. eCollection 2025.

GATA Transcription Factors: A Cross-Road for Erythropoiesis, Neurodevelopment, and Synucleinopathies

Bellomi F, Caturano C, Velardi V, Mancinelli R, Carotti S, Vivacqua G, Arciprete F, Zingariello M.

Dev Neurobiol. 2025 Jul;85(3):e22975. doi: 10.1002/dneu.22975.